Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Y J L Jansen, E A Rozeman, R Mason, S M Goldinger, M H Geukes Foppen, L Hoejbergs, H Schmidt, J V van Thienen, J B A G Haanen, L Tiainen, I Marie Svane, S Mäkelä, T Seremet, A Arance, R Dummer, L Bastholt, M Nyakas, O Straume, A M Menzies, G V LongV Atkinson, C U Blank, B Neyns

162 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences